Dexcom (DXCM) Total Debt (2010 - 2025)

Dexcom's (DXCM) quarterly Total Debt came in at $1.2 billion in Q3 2025, little changed quarter-over-quarter from $1.2 billion in Q2 2025.

Analysis

Dexcom (DXCM) Total Debt (2010 - 2025) Analysis & Trends

Dexcom (DXCM) has reported Total Debt for 12 consecutive years, with $1.2 billion the latest figure, recorded in Q3 2025.

On a quarterly basis, Total Debt changed N/A year-over-year to $1.2 billion in Q3 2025; TTM through Sep 2025 was $1.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 billion, changed N/A from the prior year.
Total Debt was $1.2 billion for Q3 2025 at Dexcom, roughly flat from $1.2 billion in the prior quarter.
Over five years, Total Debt peaked at $1.2 billion in Q3 2025 and troughed at $124.2 million in Q3 2023.
A 4-year average of $908.3 million and a median of $989.1 million in 2023 frame the typical range for Total Debt.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	183.51 Bn	177.91 Bn	7.27 Bn	32.61 Bn
2	Intuitive Surgical	124.70 Bn	119.48 Bn	1.96 Bn	-
3	Medtronic	117.95 Bn	109.13 Bn	6.34 Bn	28.15 Bn
4	Stryker	106.08 Bn	102.61 Bn	4.50 Bn	14.94 Bn
5	Boston Scientific	66.53 Bn	65.99 Bn	3.85 Bn	12.62 Bn
6	Edwards Lifesciences	49.51 Bn	45.26 Bn	1.35 Bn	598.70 Mn
7	Alcon	33.90 Bn	32.44 Bn	1.68 Bn	4.15 Bn
8	Dexcom	32.09 Bn	30.14 Bn	830.00 Mn	-
9	Steris	21.06 Bn	20.58 Bn	684.20 Mn	2.14 Bn
10	Zimmer Biomet Holdings	18.27 Bn	17.86 Bn	1.54 Bn	7.48 Bn

Historic Data

Download Data